GlassScriptPhysician profile
Sean Douglas Morgan
NPI 1760240543
$1,208.09
in general payments reported to CMS, 2019-2025
11 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $145 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $661 · Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $660.75 |
| Food and Beverage | $547.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $730.56 | 2025 | Iovera |
| Tricoast Surgical Solutions LLC | $108.77 | 2025 | |
| Medical Device Business Services, INC. | $92.65 | 2025 | |
| Joint Restoration Foundation, INC. | $82.97 | 2024 | |
| Baxter Healthcare | $54.91 | 2025 | Floseal |
| Bioventus LLC | $40.14 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $25.51 | 2025 | Zynrelef |
| Davol INC. | $22.76 | 2024 | Arista Ah Flexitip |
| Convatec INC. | $17.95 | 2025 | |
| Avanos Medical | $16.74 | 2025 | |
| Solventum Corporation | $15.13 | 2024 | V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.